The present invention is directed to novel compounds of Formula (I) for use in the treatment of diseases in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred.
申请公布号
WO0239954(A3)
申请公布日期
2003.04.03
申请号
WO2001US43814
申请日期
2001.11.20
申请人
SMITHKLINE BEECHAM CORPORATION;ADAMS, JERRY, L.;BRYAN, DEBORAH, L.
